Advertisement

Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension incidence in Latvia in 2018

      Pulmonary hypertension (PH) is a heterogeneous group of disorders that can be classified according to clinical, hemodynamic and pathological findings and the prognosis of each group differs substantially [
      • Galiè N.
      • Humbert M.
      • Vachiery J.-L.
      • Gibbs S.
      • Lang I.
      • Torbicki A.
      • et al.
      2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension.
      ]. Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are distinct types of pre-capillary PH, defined by mean pulmonary arterial pressure (mPAP) >20 mmHg, pulmonary arterial wedge pressure (PAWP) ≤15 mmHg and PVR ≥ 3 Wood units [
      • Simonneau G.
      • Montani D.
      • Celermajer D.S.
      • Denton C.P.
      • Gatzoulis M.A.
      • Krowka M.
      • et al.
      Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Galiè N.
        • Humbert M.
        • Vachiery J.-L.
        • Gibbs S.
        • Lang I.
        • Torbicki A.
        • et al.
        2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension.
        Eur Heart J. 2016; 37 (The Oxford University Press): 67-119
        • Simonneau G.
        • Montani D.
        • Celermajer D.S.
        • Denton C.P.
        • Gatzoulis M.A.
        • Krowka M.
        • et al.
        Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
        Eur Respir J. 2019 Jan 24; 53 (pii: 1801913)https://doi.org/10.1183/13993003.01913-2018
        • Wilkens H.
        • Konstantinides S.
        • Lang I.M.
        • Bunck A.C.
        • Gerges M.
        • Gerhardt F.
        • et al.
        Chronic thromboembolic pulmonary hypertension (CTEPH): updated recommendations from the Cologne Consensus Conference 2018.
        Int J Cardiol. 2018 Dec 1; 272S: 69-78https://doi.org/10.1016/j.ijcard.2018.08.079
        • Hoeper M.M.
        • Humbert M.
        • Souza R.
        • Idrees M.
        • Kawut S.M.
        • Sliwa-Hahnle K.
        • et al.
        A global view of pulmonary hypertension.
        Lancet Respir Med. 2016; 4 (Apr): 306-322https://doi.org/10.1016/S2213-2600(15)00543-3
        • Peacock A.J.
        • Murphy N.F.
        • McMurray J.J.
        • Caballero L.
        • Stewart S.
        An epidemiological study of pulmonary arterial hypertension.
        Eur Respir J. 2007; 30: 104-109https://doi.org/10.1183/09031936.00092306
        • Humbert M.
        • Sitbon O.
        • Chaouat A.
        • et al.
        Pulmonary arterial hypertension in France: results from a national registry.
        Am J Respir Crit Care Med. 2006; 173: 1023-1030https://doi.org/10.1164/rccm.200510-1668OC
        • Escribano-Subias P.
        • Blanco I.
        • López-Meseguer M.
        • the REHAP investigators
        • et al.
        Survival in pulmonary hypertension in Spain: insights from the Spanish registry.
        Eur Respir J. 2012; 40: 596-603https://doi.org/10.1183/09031936.00101211
        • Sablinskis K.
        • Sablinskis M.
        • Lejnieks A.
        • Skride A.
        Growing number of incident pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients in Latvia: a shifting epidemiological landscape? Data from a national pulmonary hypertension registry.
        Eur J Intern Med. 2019; 59 (Jan): e16-e17https://doi.org/10.1016/j.ejim.2018.09.017
        • Skride A.
        • Sablinskis K.
        • Lejnieks A.
        • Rudzitis A.
        • Lang I.
        Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe.
        Pulm Circ. 2018; 8 (Jul-Sep)https://doi.org/10.1177/2045894018780521
        • Humbert M.
        • Simonneau G.
        The need for national registries in rare diseases.
        Am J Respir Crit Care Med. 2006; 174: 228a-229https://doi.org/10.1164/ajrccm.174.2.228a